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Foreword 
That American business can benefit from technological ad- 
vances prompted by requirements for space missions is b m m -  
ing obvious. That research sponsored by the National Aero- 
nautics and Space Administration also may help prolong 
thousands of persons' lives is less generally realized. This sur- 
vey of recenit developments in cardiovascular monitoring em- 
phasizes applications of achievements in aerospace work to 
civilian medicine. 
The Teohnology Utilization Division of NASA was estab- 
lished to disseminab information rapidly that appears likely 
to be useful in industry. Members of the staff of the Bioen- 
gineering and Biosciences Technology Department of 6he West- 
inghouse Electric Corporation Research Lgboratories in Pitts- 
burgh undertook this survey for NASA. Their report both 
reviews several significant developments and discusses the 
potential market for new products *hat now can be readily 
envisioned. 
GEORGE J. HOWICX, 
Director, Technology Utilization Diwision, 
National Aeronazctics and Space Adminhtration 
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CHAPTER 1 
Scope of This Study 
Physiological monitoring is the continuous or periodic measurement 
of quantitative physiological data in a form suitable for evaluation, 
recording or storage. This monograph is concerned primarily with 
these techniques as they apply to an intact human subject, although 
many of them am equally applicable to other biological subjects. 
Most physiological monitoring systems are designed to measure prop- 
erties of the organism ikself; however, some measurements of the 
physical properties of the organism's environment may have sufficient 
biological significance to warrant classification as physiological 
monitoring. 
Physiological monitoring systems consist of three primary elements : 
the transducer or sensor which performs the actual measurement, the 
communication equipment which transmits this data from the point 
of measurement to the point of analyses or reproduction, and the data 
handling system which analyzes, reproduces and/or stores the data. 
The transducer or sensor detects the values of the biological param- 
eters and makes them available for measurement. The term trans- 
ducer ordinarily denotes a device which transforms energy in one 
form to energy in another form. Many physiological transducers 
operate by transforming heat, motion, pressure, etc., into electrical 
signals. Exceptions are those "transducers" which are used to meas- 
ure bioelectric phenomena. Electrodes used to detect potential differ- 
ences for instance do not transform energy but, together with asso- 
ciated amplifiers and signal conditioning equipment, make it available 
f o ~  measurement. 
The communication sub-system consists of three elements : the data 
transmission device which receives energy from the transducer and 
transmits it, the communication link, and the data receiving unit. The 
communication link may be either wired or wireless. The data trans- 
mitter usually amplifies, conditions, and modulates the signal received 
from the transducer before transmitting it to the data receiving unit. 
At the receiving unit, the signal is demodulated and often further 
amplified. 
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A variety of data reproduction units may be used with physiological 
monitoring systems. Almost.any unit which generates a visual dis- 
play may be used to exhibit the measurements in real time (as they 
are received). Oscillographs, typewriters, and other printing units 
that produce records may provide both a real time visual display of the 
measurements and a permanent record of the data. Sometimes the 
data is analyzed and certain computed functions are displayed instead 
of or in addition to the signal itself. The signal obtained from an 
electrocardiogram, for example, can be processed to provide pulse 
rate and acceleration, and quantitative respiratory data. In  a more 
sophisticated system, data analysis could be routinely performed and 
only unusual or significant deviations from the normal or expected 
values displayed or recorded. This would enormously decrease the 
amount of data to be examined. 
In  surveying physiological monitoring systems and their applica- 
tions, we have focused attention on the sensors involved. These ele- 
ments are of necessity tailored specifically for biomedical use, while 
data transmission and data handling systems differ only slightly from 
those used in other sensing and display systems. Current and previ- 
ous surveys have covered the major technological advances in these 
areas. 
The primary emphasis of this report is upon the methodology in- 
volved in making physiological measurements and the sensing systems 
used. This limitation in scope, however, is not intended to derogate 
the importance of other areas in the development of practical moni- 
toring systems. In  fact, one of the major stumbling blocks to the 
use of continuous monitoring techniques is the vast amounts of data 
generated, and the subsequent need for an intelligent programmed 
technique for analyzing and evaluating it. Such techniques are in- 
deed essential to the extensive use of continuous monitoring techniques. 
A further reduction in the scope of this study is in regard to the 
physiological systems considered. The circulatory and respiratory 
systems are inherently and directly sensitive to the environmental 
conditions of space flight, and consequently a preponderance of 
NASA-supported research and development efforts have been con- 
cerned with monitoring of the significant parameters of these systems. 
For the respiratory system, the principal efforts were to evaluate and 
adapt existing monitoring techniques to the flight application. How- 
ever, existing monitoring techniques for the circulatory system were 
inadequate, and a concentrated effort was necessary to produce ac- 
ceptable flight hardware. In  view of current medical interest in 
the treatment of certain types of heart disease in special coronary 
care wards equipped for continuous monitoring of circulatory param- 
Superior figures refer to References on p. 43. 
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eters, technology concerned with the circulatory system may now 
have considerable economic significance. 
This n~onograph was written to encourage the commercial exploita- 
tion of this technology by industrial organizations that are willing 
to undertake such further development or adaptation as may be re- 
quired to render these devices and techniques useful to civilian 
medicine. It is also intended to serve members of the biomedical 
community ~ ~ h o  need new techniques but may not be aware of the 
technological advances resulting from the space effort. 
The literature surveyed was limited by design to unclassified, un- 
limited distribution documents. Some errors of omission and com- 
mission have undoubtedly occurred. A number of NASA advances 
were alluded to in the general literature, but in many cases detailed 
development reports were not available; thus these developments 
could not be well evaluated. 
No evaluation of the potential for transfer of technology from in- 
directly related fields has been attempted. Typical examples of such 
indirect transfers that have occurred in the past are the use of space- 
developed gas bearings in ballistocardiography and electronic filtering 
techniques in phonocardiography. 

CHAPTER 2 
Techniques of Cardiovascular Monitoring 
Before describing NASA advances in cardiovascular monitoring, 
we shall briefly discuss the nature and significance of the system 
parameters measured and the present and proposed techniques for 
monitoring these parameters. 
The circulatory (or cardiovascular) system consists of the h a r t  
and blood vessels which distribute nutrients and oxygen to all parts 
of the body and carry away the wastes and carbon dioxide produced. 
Of major importance in monitoring the activity of this system are the 
electropotentials generated by the heart muscles (electrocardiog- 
raphy), heart sounds (phonocardiography ) , blood pressure and oxy- 
genation, pulse rate and rate of change, and flow rate of blood through 
specific arteries or body tissues. 
BLOOD PRESSURE 
Blood pressure is the result of the pumping action of the heart 
which empties 'blood into a closed system of elastic blood vessels. The 
volume capacity of this system changes as a result of the stretching of 
the vessels and by caliber changes in response to nervous and chemical 
stimuli. 
During ventricular systole, blood is forced into the highly elastic 
arterial system faster than it can escape into the arterioles, capillaries 
and veins, and the arteries are stretched to greater capacity. But since 
blood is constantly passing into the capillaries, the pressure falls when 
the flow of blood into the arteries is stopped at  the end of ventricular 
systole. The elastic recoil of the arterial walls forces the blood on- 
ward through the capillaries at a constantly decreasing pressure until 
the arteries regain their pre-systolic caliber. The energy that was 
stored in the arterial walls during the stretching of the vessels is ex- 
pended between heart beats, insuring a relatively continuous flow of 
blood through the arterioles and capillaries. The pulsations of the 
arteries are convenient indications of heart rate. 
The blood pressure is maintained at  a normal level by a combination 
of five factors: cardiac output, peripheral resistance, blood volume, 
elasticity of the arterial walls and blood viscosity. 
5 
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Blood pressure is a major parameter in monitoring the circulatory 
system. The pressures recorded at various points on the body are 
different, however, since blood would not flow if there were not a 
pressure gradient from the large arteries to the smaller arteries, the 
arterioles, the capillaries and the veins. Therefore, to be comparable, 
blaod pressure information mnst be recorded at the same place. Al- 
most all blood pressure measurements are presently made on the fore- 
arm. At this location, it is quite easy to measure both systolic pressure 
(the maximum pressure which occurs during ventricular systole) and 
diastolic pressure (the minimum pressure which occurs as a result of 
arterial recoil during ventricular diastole). The difference between 
the systolic and diastolic pressures is called the pulse pressure. 
BLOOD PRESSURE MEASUREMENT BY OCCLUSION 
A physician normally measures arterial pressure by encircling the 
arm with an inflatable cuff, and placing a stethoscope, microphone, or 
other listening device over the brachial artery below the cuff in a posi- 
tion where the pumping sounds of the heart are clearly audible. The 
cuff is inflated until the pressure in the cuff is greater than the arterial 
pressure; a t  this point, no sounds are heard, since arterial pressure is 
insufficient to force blood past the cuff. Tlze pressure in the cuff is 
released slowly until the lumen in the compressed artery is opened 
enough to allow the passage of a jet of blood with each heart beat 
(ventricular systole). The pressure in the cuff a t  this point, recog- 
nized by the sound of the pulsing blood flow in the partially occluded 
artery (Korotkoff sounds), represents the systolic pressure. As the 
cuff pressure is reduced further, the sounds change in quality and 
disappear completely when the blood flows continuously through the 
artery. The pressure in the cuff at this point is the diastolic pressure. 
This general technique of blood pressure measurement by occlusioil 
and detection of pulsatile blood flow can be used at almost any point 
on the body where a uniform pressure field can be applied to an 
artery. The ausculatory (lietening) method is extremely sensitive to 
noise artifacts which makes automatic interpretation of the data diffi- 
cult to perform reliably. Ot-her methods available for the detection 
of pulsatile blood flow include electrical impedance plethysmography 
and ultrasonic and electromagnetic flow meters. (These techniques 
are discussed in detail later in connection with blood flow rate 
measurement.) 
The changing opacity of flesh to light can also be used to indicate 
changes in blood flow rate or volume. Either reflected or transmitted 
light may be employed. Disadvantages of the reflective technique 
include increased susceptibility to motion artifacts, reduced sensitivity 
due to direct light transfer over the skin surface, and the effect of 
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skin color upon the output. The transducer may be located a t  almwt 
any convenient site on the body. I n  contrast, the transmitted light 
technique requires that the transducer be placed on a site where it 
can sasily straddle a web of flesh. 
Several methods have been proposed that use the motion or force 
that a pulsating artery imparts to the skin a~ an indication of blood 
flow. When transmitted to the skin, however, any physical changes 
imparted by the vascular system are extremely small compared to 
motion produced by normal activity. Thus, such systems are extremely 
sensitive to motion artif a d .  
BLOOD PRESSURE MONITORING 
Blood pressure may be monitored by partially or completely auto- 
mating the occlusive procedure. The occlusive device is pressurized 
rapidly to a level above any anticipated syetolic pressure, after which 
the pressure is gradually reduced. The initiation and cessation of 
pulsatile blood flow are detoded by the transducer and when combined 
with a pressure signal from the occluding ,device, produce an indication 
of systolic and diastolic blood pressure. 
Cyclic-occlusion techniques have several inherent limitations. The 
long period required to make a single d&erminakion of systolic and 
diastolic pressure obviously makes this technique somewhat less satis- 
factory than a dynamic measurement. The major disadvantage, how- 
ever, is that the cyclic-occlusive phenomena produces considerable dis- 
comfort when used continuously on a major artery. If used on a 
minor artery or arteriole, continuous measurements may be possible, 
but the inherent accuracy of measurement on the peripheral circula- 
tion system is limited. All the influences related to the change of 
peripheral circulatory resistance, such as temperature, position and 
the autonomic nervous system, present complications in the measuring 
problem and may profoundly influence the displayed values of arterial 
blood pressure. 
NON-OCCLUSIVE INDiRECT METHODS 
Several methods of indirect non-occlusive measurement of blood 
pressure have been proposed, but the transducer remain6 the difficult 
area of development. At present, the most promising method appears 
to be the direct force-balance probe which is placed against the arterial 
wall (or the tissue directly above ist). The transducer is respon~ive 
to the arterial pressure wave and can display the dynamic waveform, 
but there are still many problems associated with this method. The 
- 
exact placement of the transducer over the arterial wall and the main- 
tenance of this position is the major obstacle. This is true of all of 
the probe balance systems presently under investigation. 
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Pulse wave velocity has been advocated as an indirect measure of 
blood pressu.re, buk many investigators strongly believe that the re- 
liability of thie technique is questionable. 
PULSE RATE 
As blood leaves the heart under high pressure, some of its flow 
energy is expended in distending the elastic walls of the large arteries. 
The recoil of these arteries then forces the blood through the system 
after ventricular systole. This distension ana recoil is responsible for 
the pluse wave which can be felt in any artery. A pulse occurs with 
every systole; therefore, the pulse rate can be measured to determine 
heart rate. 
A transducer may be placed over any artery to pick up the pulse. 
The most common position is on the wrist where the radial artery runs 
just below the skin. Pulse rate or heart rate also may be measured by 
using electrocardiographic leads to pick up cardiac muscle potential. 
I n  this case, the potential picked up by the leads is passed through a 
filter to eliminate high frequency electromyographic potentials. The 
resulting wave is clipped so that only the peak of the ventricular 
systole potential remains, and this information is amplified and fed 
into a counter (cardiotachometer) to record the heart rate. 
Gross body movement and muscular activity create random signals 
that interfere with pulse rate measurements at  the wrist or at  the 
chest. All types of instrumentation for measuring pulse rate require 
filters to eliminate these random signals. In  addition, there are other 
problems resulting from the use of electrocardiographic leads to 
record pulse rate which are similar to those described for monitoring 
the cardiac cycle. 
I 
CARDIAC ACTIVITY 
Cardiac activity is commonly monitored by the (1) electric 
potentials stimulating the contracting heart muscles (eleotrocardiog- 
raphy), (2) small movements produced in various parts of the body 
under (the influence of displacement of the heart and blood (ballisto- 
cardiography, vibocardiography, etc.) , or (3) heart sounds obtained by 
intracardiac catheterization or by acoustic pickup with a chest micro- 
phone (phonocardiography ). 
ELECTROCARDIOGRAPHY 
The activities of the cardiac muscles, as previously noted are 
initiated by electrical changes. These potential changes are trans- 
mitted to the surface of the body where they may be recorded and 
correlated with heart action. Since it is important for standardization 
purposes that potentials be read from the same places each time, and 
since the limbs are the only locations that are equipotential over a 
large area, three standard combinations of instrument lead connections 
have been adopted universally. Standard limb lead I measures the 
potential difference between the right and left arms; lead I1 measures 
the potentkl between the right arm and left leg ; and lead I11 measures 
the potential between the left arm and left leg. 
Electrocardiography has well-established standard values that are 
given in numerous handbooks. Primarily, the electrocardiogram per- 
mits the monitoring of the electrical signals which control the heart 
rate and rhythm. The frequency of ventricular systole indicates the 
heart rate. Also, the presence of fibrillation (and premature atrial 
contractions), tachycardia, heart block and hypoxia oan be detected 
from the EKG. 
Since the peak voltage appearing in an electrocardiograph signal 
using standard electrode arrangements is approximately 2 millivolts, 
the signal must be amplified considerably, and the amplifiers and re- 
cording equipment must be selected carefully to avoid introducing 
excessive artifacts. The electrodes must not be placed over large 
muscle masses where they can detect electromyographic potentials. I n  
addition, they must be attached to the body firmly to prevent the skin 
from moving beneath the electrodes. Artifacts are introduced through 
impedance changes resulting from changes in galvanic skin reflexes, 
but little can be done about these except to try to avoid locations where 
there are numerous sweat glands, and to recognize the artifacts when 
they appear in the record. 
BALLISTOCARDIOGRAPHY 
Ballistocardiography is the measurement of the total body motions 
produced in response to the pumping actions of the circulatory system. 
The measurement of this parameter has evolved along two basic lines. 
In  the first technique, ultra-low frequency devices attempt to support 
the body in the direction of interest with a spring-damping system 
which has a natural frequency much less than the exciting frequency 
of the cardiovascular activity. A second technique uses a high fre- 
quency suspension system and attempts to measure forces without 
motion. This technique allows the natural resilience of the body to 
play an important role. 
Despite practical difficulties with equipment and artifacts, ballisto- 
cardiography is an impressive prognostic tool. The diagnosis of 
coronary deficiencies is claimed to be practical, but the real value to 
date has proven to be in the area of qualitatively evaluating the 
myocardium. 
221-968 046----3 
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APEXCARDIOGRAPHY 
Apexcardiography is the measurement of the displacements of the 
precordial area immediately over the apex of the heart. These low 
frequency displacements of 0.1 to 20 cps indicate information relative 
to certain anatomic factors in the same manner as manual palpation 
of the pericardium but with greatly extended sensitivity. Atrial and 
ventricular hypertrophy is made evident, and certain valvular mal- 
functions can be ascertained. 
VIBROCARDIOGRAPHY 
Vibrocardiography is the measurement of the acceleration produced 
at the chest wall by the pumping motion of the myocardium. This 
technique is also known as the precardial ballistocardiogram, stetho- 
gram, mechanogram and kinetogram. The vibrocardiogram can be 
obtained by differentiating the apexcardiogram twice (and vice versa) 
if comparable frequency response transducers are used. The informa- 
tion is essentially the same, but the acceleration display delineates 
certain periods of the cycle more clearly. The duration of the isometric 
contraction and the ejection phase can be accurately measured, and 
it is believed that these two parameters are valuable in estimating the 
strength of the heart. 
The biggest single problem confronting this and related techniques 
discussed above is that of attaining general acceptance as valid diag- 
nostic and prognostic information. Much of this difficulty is caused 
by the lack of a uniform technique and instrumentation. Noise and 
spurious signals have also been a serious problem. Generally speaking, 
the major limitation involved with this technique is physiologic and 
anatomic correspondence. The cardiovascular system is extremely 
complex and its external manifestations present investigators with a 
large number of unexplained physiological phenomena. 
PHONOCARDIOGRAPHY 
Phonocardiography is an objective method of graphically present- 
ing the sound vibrations produced by the action of the heart. It differs 
from vibrocardiography only in the frequency range of interest. 
Cardiac auscultation is one of the classic diagnostic methods obligatory 
in the examination of a patient ; it usually yields the most complete 
presentation of the dynamics of cardiovascular activity and its dis- 
orders. However, the subjective character of auscultation and the 
limitations of the human ear in an analysis of time relationships 
eventually led to phonocardiography as a more objective method of 
presenting heart sounds. The normal phonocardiogram presents the 
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change of sound pressure with time, although ,a spectrum analysis 
presentation is also used. 
BLOOD FLOW RATE 
Measurement of blood flow rate is important for detecting changes 
in the inkernal resistance of blood vessels as well as for diagnosing 
circulatory ailments. The flow of blood may be monitored directly by 
electromagnetic and sonic flow meters. Electromagnetic flow meters 
employ an electromagnetic field in which a blood vessel is placed. The 
flow of the conductive fluid (blood) through this magnetic field gen- 
erates a potential difference across the vessel which can be directly 
or indirectly measured. 
Ultrasonic blood flow meter techniques involve signal injection into 
an artery and downstream detection of the transfer of this signal 
which is modified by blood flow. Systems utilizing this technique 
are troubled by coupling problems at the input and output sites, arti- 
facts, and critical placements of the transducers. 
Plethysmography offers the advantage that the veins or vessels 
need not be exposed to be monitored. With impedance plethysmo- 
graphic techniques, the change in the volume of body tissues is used to 
indicate the quantity of blood they contain. A low voltage, radio- 
frequency signal is passed through the subject's finger or some other 
portion of the body. The received signal indicates the rhythmical 
variations in electrical impedance resulting from pulsatile volume 
changes (and consequently heart beat). This impedance curve may 
be correlated with cardiac output, or the information may be fed 
into a differentiating network to yield the relative change in the 
velocity throughout the cardiac cycle in a given pulse region. This 
technique is generally considered "delicate" and difticult to standardize. 
Blood flow rate also may be monitorized by plethysmographic 
methods using strain-type gages. A strain gage is connected to a 
strap encircling the subject's finger, arm or calf to measure the girth 
of the limb. An occluding cuff is provided below the gage to occlude 
arterial flow (except on the finger), while another cuff above the gage 
(on the heart side) occludes venous flow. The change in girth may 
be calibrated to record flow rate. This type of device could be inte- 
grated with the occluding cuff used for determining blood pressure, 
thereby reducing the discomfort to the subject being monitored. 
OXYGEN SATURATION OF BLOOD 
The oxygen saturation of the blood may be determined by measuring 
the percentage of hemoglobin in the blood in oxygenated form with a 
photoelectric photometer. Oxygenated and reduced hemoglobin 
absorb light of wavelengths in the region of 640 millimicrons (red) 
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quite differently, while light of 800 millimicrons wavelength is ab- 
sorbed equally by both forms of hemoglobin. A device can be con- 
structed, therefore, using a photocell for each wavelength (640 and 
800 millimicrons). Thp light of each wavelength is transmitted 
through a thin section of the body, such as the projecting part of the 
external ear, and is detected by the photocells. The difference between 
the readings at each wavelength is a function of the oxygen satura- 
tion of the blood. 
To correct for the ear tissue interposed in the optical path of the 
device, a pressure device (mechanical or pneumatic) can be used to 
force blood from the ear so that the light absorption of the bloodless 
tissue can be measured. The light absorption of the blood alone would 
be the difference between the readings with the ear occluded and with 
the ear open to circulation. This technique is subject to artifacts 
from acceleration forces and vibration that affect equipment 
performance. 
CHAPTER 3 
NASA Technological Advances 
NASA has supported a variety of in-house and industrial programs 
to develop physiological monitoring systems to be used in the space 
program. This section will briefly review the major technological 
advances most applicable to patienk monitoring. The status of these 
developments is evaluated in terms of the required performance, and 
the remaining development or adaptartion is identified. 
Our review is limited to those areas in which major technological 
advances were achieved through a computer search of NASA un- 
classified, unlimited distribution documents. Briefly, these include 
the indirect measurement of blood pressure, new EKG electrode tech- 
niques, and vibrocardiography. The use of an electrical impedence 
pneurnograph to monitor respiratory rate and volume appears to be a 
significant advance, but sufficient evidence was not available to clearly 
identify NASA's role in the development or adaptation of this device. 
BLOOD PRESSURE 
Research and development in blood pressure measurement has pro- 
ceeded in several directions. An automated sphygmomanometer sys- 
tem for periodic blood pressure measurement was developed and used 
in the flight program. Concurrently, a major effort was carried on to 
develop an indirect lion-occlusive blood pressure monitoring technique 
that could be used continuously with lithle or no inconvenience to the 
subject. However, because of a decision not to monitor blood pressure 
on Apollo flights, some promising devices and techniques were only 
pa&ially developed or tested. Many of these show considerable 
promise for clinical use. 
AUTO-SPHYGMOMANOMETER 23 
On Mercury and Gemini flights, an automated sphygmomanom- 
eter system has been used that AiResearch developed under contract 
to NASA. I t  is based on the same principle used in clinical sphygmo- 
manometry. An inflatable occluding cuff on the left arm is inflated to 
a pressure in excess of the maximum expwted value of systolic 
pressure. As the pressure gradually decreases, a microphone under 
13 
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the lower half of the cuff over the brachila1 ,artery listens for the 
Korotkoff sounds indicative of pulsatile blood flow. The signal from 
the microphone is amplified and mixed with a signal from a pressure 
transducer which transmits the cuff pressure. I n  order to determine 
the systolic and diastolic pressure i t  is necessary to identify the points 
of inception and cessation of the microphone signal on the cuff pressure 
signal. 
As originally conceived, the blood pressure measuring system 
(BPMS) would be initiated from a tracking station through the com- 
mand receiver, by an aukmatic sequencing device on board, or by the 
pilot. The automatic system included special safety circuits to dump 
the cuff pressure if the cuff sbayed hove  60 mm Hg  for more than 2 
minutes. This feature provided for a situiation in whiah the pilot 
was unconscious and the automakic system failed to bleed off the cuff 
pressure. The cuff pressure in the automatic system was decreased in 
a linear manner from 220 mm Hg  to 60 mm H g  by a special pressure 
regulakor in which the reference spring tension was varied by a motor- 
driven cam. The pneumatic system consisted of an oxygen storage 
flwk, solenoid fill valve, motor-driven regulator, dump solenoid valve, 
cuff pressure transducer and suit reference manifold. 
When the preliminary system, was twted on astronauts snd other 
flight personnel it became evident thak the standard 5-inch clinical 
cuff was unsatisfactory because of i,ts stiffness, bulk, and restridion 
to arm movement. A new cuff (Figure 1) was devised by NASA 
which was acceptable on all points and is almost unnoticeable when 
not inflaked. Tests were performed to compare the new cuff with the 
standard cuff and the resulting data were identical. It is believed 
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that the new cuff type can be used wherever comfort, light weight, ease 
of 'application and unrestricted arm motion &are desired. 
I f  the microphone signal is filtered so that only frequencies between 
32 and 40 cps are used, the various artifacts due to movements and 
ambient noise level are greatly attenuated, while the component that 
allows the discrimination of the systolic and diastolic points is passed. 
A specially damped, piezoelectric microphone was developed for 
flight use. The instrument is about 3.5 cm in diameter and 0.5 cm thick 
and is so constructed that sensitivity to ambient noise is greatly re- 
duced. The microphone signal leaves the suit through the bioconnec- 
tor and enters the amplifier in the blood-pressure unit. The BPMS 
amplifier consists of a shielded preamplifier and two high-gain ampli- 
fiers which determine the response characteristics. Each amplifier is 
designed to have greatly attenuated response outside the 32 to 40 cps 
band by means of R-C filtering circuits in each feedback Imp. The 
amplifier output is gated so that unless a signal of sufficient amplitude 
is present there is no output signal, and this gating results in a marked 
reduction in the output noise level for improved readability of the 
signal. 
The cuff pressure is measured by a potentiometer-type transducer 
powered by two mercury batteries to give the zero-centered + 1.5 volt 
output necessary for telemetering. The signal from the pressure trans- 
ducer passes through a miniature transformer where it is mixed with 
the output from the microphone and then on to the output clipping cir- 
cuits that protect the telemetry system from excessive voltages that 
can cause cross-channel inkrf erence. 
To compare this method with direct arterial measurement, a special 
centrifuge unit was fabricated and installed on the human centrifuge 
at the University of Southern California (USC). Then a series of 
tests was performed by personnel from USC, NASA, McDonnell, and 
AiResearch. Subjects equipped with the blood pressure measuring sys- 
tem on the right nrm and an arterial catheter on the left arm were tested 
at various acceleration levels. Spot checks were also made with a 
clinical cuff and stethoscope. The results showed that at 1 g the BPMS 
read about .5 mm lower on systole and about 5 mm higher on diastole 
compared with the direct arterial readings. 
There was an increased scatter in the points as acceleration increased 
which is thought to have been partly due to the ;'eyeballs down" posi- 
tion of the subject causing a pooling of blood in the lower arm. Com- 
parison of the data from the BPMS with clinical and arterial tests can 
be summarized as follows : The BPMS is more accurate than the clin- 
ical method when both are compared with the direct arterial measure- 
ments, 'and the BPMS readings compared with the clinical readings 
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are higher on systole and lower on diastole, a fact which is probably due 
to the increase in sensitivity of the microphone over the stethoscope. 
Problems in spacecraft integration later required the elimination of the 
gas pressure source, regulator, and motor programmer and the installa- 
tion of a hand-pumped inflation system with a simple orifice to release 
cuff pressure. Subsequent flight systems provided a gas pressure 
source and a simple switch actuation to initiate the cycle. 
DIRECT FORCE BALANCE PROBE 3s * 
The direct force concept of arterial blood pressure measurement 
originated at the Stanford Research Center under NASA funded re- 
search studies. The objective of this research was to investigate tech- 
niques fcr the continuous monitoring of arterial blood pressure by ex- 
ternal means. It was required that the transducer be designed so as not 
to encumber the subject and not itself affect the pressure being meas- 
ured. 
Initial work was directed toward measurement of superficial effects 
of arterial distention. Measurements were conducted in an effort to 
relate skin displacement above an artery to blood pressure causing 
arterial distention. Several skin deflection transducers were designed 
and constructed that measured the difference between the skin elevation 
directly over the artery and the skin elevation adjacent to the artery, 
and a novel method of applying a constant force to hold a transducer 
against the skin was devised. These techniques resulted in a reasonably 
stable measuring system that would respond to changes of skin 
elevation. 
During the course of the project, however, i t  was determined that 
skin displacement effects could not be related to blood pressure to 
the exclusion of other physiological influences such as skin tension 
and muscle tone. For example, certain drugs for the reduction of 
blood pressure have an effect on the patient's tissue tone such that 
arterial distention actual increases. The displacement type transducer 
would then measure an increase instead of a decrease in blood pressure. 
During the Stanford research, an alternate concept of a direct force 
type of measurement evolved. This technique involves restraint of 
the arterial deflection and simultaneous measurement of the force 
required to provide the restraint. This effectively immunizes the 
transducer against khe effeots of variations and non-linearities in skin 
and tissue elasticity by reducing the skin deflection to a negligible 
value. 
Transducer Design and Construction 
To obtain a more accurate description of the nature of this blood 
pressure measuring system, a mathematical model of the system 
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characteristics was used. This model was based on the assumption 
that the deflections involved are so small that non-linearities are in- 
significant, and therefore compressible and extensible tissues are rep- 
resented as linear springs. The artery is assumed to rest on a firm 
base, to have elastic walls, and to be surrounded by uniform tissue. 
The transducer is assum.ed to have side structures to allow it to rest 
on the skin, and a center structure that responds to arterial pressure. 
Design of the direct force measuring transducer was based on the 
requirements resulting from the consideration of this mathematical 
model. Since the basic assumptions that determine the validity of 
this model demand that the deflections of the skin surface and artery 
be small to avoid non-linearities, it is essential that the transducer 
spring constant be much greater than the effective spring constant 
which normally determines arterial deflection. An additional require- 
ment that must. be satisfied for the practical utilization of this tech- 
nique is that the arterial rider diameter be somewhat smaller than 
the artery to provide assurance that it can be easily positioned entirely 
over the artery. 
Previous measurements with the deflection transducer had revealed 
the unrestrained motion of the skin surface over the temporal artery 
to be approximately 120 micro-inches with a pulse pressure of 40 mm 
Hg. To obtain a true force measurement, the transducer spring con- 
stant was made about ten times as great, producing a resultant deflec- 
tion on the order of 12 micro-inches. 
The sensing element used in the first transducer vas  a semi-conductor 
strain gage with a gage factor of 110. The arterial rider was 0.065 
inches wide and 0.250 inches long, with a resulting rider area of 0.0156 
square inches. The arterial pulse pressure of 40 mm Hg. (0.77 psi) 
produces a rider force of 0.0121 1b. Thus, Ito limilt arterial deflection 
to 12 micro-inches, a spring constant of approximately 1000 Win. was 
utilized in the form of a simply supported beam. 
The rider dimensions were a compromise between the small size 
needed to position the rider over an a~ te ry  and a size sufliciently 
large to provide adequate force and signal level. Taken together the 
requirements for a stiff transducer and small rider resulted in quite 
low levels of strain in the beam. I n  practice, pulse ampliltude levels 
of 650 microvolts were recorded. Although the resulting signal levels 
were low, the low-impedance input of the system resulted in negligible 
eledrical noise, so that the signal-to-noise ratio was large. 
In  testing this gage, it was determined that the rider was still too 
large to satisfy fully the strictest requirements for using this tech- 
nique. I t  was concluded that ideally the arterial rider should be 
about 0.020 inches in diameter for application to an artery of the 
temporal group. However, several serious design penalties are en- 
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countered as the rider size and contact area are reduced. The most 
serious consequence is that as a result of the proportionate reduction 
in blood pressure force, the transducer becomes more sensitive to 
inertia forces produced by movements of the transducer. 
Another problem with this gage was its excessive temperature sensi- 
tivity, which was found to be about 2 mv per degree Centigrade, as 
compared to a pressure sensitivity of 1 mv per 100 mm Hg. It was 
concluded that temperature sensitivity must be reduced by at least an 
order of magnitude. 
Continued development resulted in an improved strain gage trans- 
ducer which displayed greater sensitivity and linearity, and greatly 
decreased temperature sensitivity. This transducer used a 0.030 by 
0.125 inch rider and was designed for use on the radial .artery. It used 
a double cantilever beam configuration (Figure 2).  
Transducer  Top- 
I Lead Wire 
No 1 
Tubi 
No 22 Hypo 
A .nd 4 r t e r i a l  Rider  
t 
~i ng 
Tube 
S e c t i o n  A-A 
FIOUBE 2.-Direct Force Strain Gage Transducer. 
TECHNOLOCIIDAL ADVANCES 19 
The general prLoblem of measuring a small force with a near-zero 
displacement has been solved in other applications through the use 
of a feedback force-balance system. This has an inherent advantage in 
that the basic position sensor need not be a linear element, but need 
only be sensitive to position and possess an inherently stable zero or 
reference position. One form of this device, using a Hall-effect trans- 
dfucer was constructed as a laboratory bench model. This device dis- 
played the basic sensitivity and stability required, but the construc- 
tion of a working blood pressure transducer of the size desired would 
have required much more development work. 
Still further work in the design of a transducer for the temporal 
artery resulted in a diaphram-suspension of differential-transformer 
design with a 0.020 inch rider diameter (Figure 3). The major 
advantages of this design over the previous strain gage models is 
that it p~rmits  greatly reduced overall size and acceleration sensi- 
tivity. Reduced acceleration response was achieved by using a mini- 
mum mass arterial rider and suspending the differential transformer 
coil, which then acted to compensate for inertia forces. 
Two models of differential transformers were constructed. The f i s t  
of these had a relatively large commercially available transformer, 
but was useful in validating the operational concept of the device. 
With this transducer it was possible to obtain calibrated pulse record- 
ings from the temporal artery. A miniature transducer specially con- 
J 
A r t e r i b  Base Plate1 Rubber 
Rider Diaphragm Box 
FIGURE 3.-Direct Force Differential Transformer Transducer. 
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structed with an l/s-inch diameter x l/s-inch high coil performed sim- 
ilarly, but presented three major areas of difficulty : 
1)  A zero-level adjustment was not provided for the core. Proper null 
settling of the core is necessary to permit higher amplifier gain 
without saturation and higher excitation frequencies with a concom- 
mitant increase in transformer sensitivity. 
2) The excitation voltage must be limited to low voltage RMS. 
3) The low impedance of transformer increases ~ens~tivity to varia- 
tion6 in cable resistance. 
Calibration 
One of the major advantages of the direct force principle of blood 
pressure measurement is that ideally, absolute calibration should be 
possible. Calibration could be performed on the instrument prior to 
use, and be independent of the individual or location. The two require- 
ments on the measuring device in order to achieve absolute calibration 
are : 
1)  The artery surface below the transducer must be flattened, 
2) The flattened area of the artery must cover the entire measuring 
surface of the transducer. 
Under these conditions the transducer can be calibrated by means 
of an "artificial artery." Presenlt transducers, however, do not appear 
to be able to produce proper calibration reliably in this manner. This 
inability to obtain absolute calibration is a difficulty shared by all 
presently available externally applied non-occlusive blood pressure 
measurement systems. The direct force system is consitdered to be the 
one concept with which it is at least theoretically possible to achieve 
an akolute calibration, and which has been shown under actual con- 
ditions to agree with such a calibration within the accuracy of the 
sphygmomanometer used for comparison. 
Problem Areas 
Prototype transducers based upon the direct force principle have 
demonstrated the validity of the technique, and displayed adequate 
accuracy, sensitivity, response anld freedom from electrical noise and 
artifacts. The major problem is the proper positioning of the trans- 
ducer over ,an artery and the maintenance of this position. 
A manual technique of moving the transducer and searching for 
the maximum pulse amplitude appears to work, but it will not give a 
subsequent indication of improper positioning if the transducer is 
accidentally moved. Studies were conducted to determine the feasi- 
bility of various methods of sensing and indicating proper position 
of the transducer over the d r y .  A method using a null signal from 
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piezoelectric pressure sensitive crystals appears to hold promise, but 
was never incorporated into a working model.5 
Even if efforts at initial positioning are successful, maintaining 
proper position is apparently very critical. Thus an effective mount- 
ing and re-locating scheme must be developed that allows the estab- 
lishment and maintenance of proper transducer position. 
EAR PULSE PRESSURE TRANSDUCERBs la 
Another method of indirect blood pressure measurement studied 
under contract to NASA wa5 an ear-located transducer which uses 
the cyclic-occlusive method. The primary advantage of this trans- 
ducer location is that continuous cyclic-occlusion of the ear pina can 
be performed with no apparent discomfort to the subject. AD inherent 
disadvantage is that ih deals with peripheral circulation, and thus 
may be susceptible to a variety -of influences which may limit it8 in- 
herent accuracy. 
Description 
The ear transducer developed for NASA by Corbin-Farnsworth, 
Inc., incorporates an annular-shaped occlusion bellows and is designed 
for installation on the ear pina. Systolic and diastolic pressure are 
detected by means of a pulsatile blood flow detector which measures 
variations in opacity of the ear capillary bed to infrared light. The 
principal advantage of this light transmission technique of detecing 
blood flow is its inherent ineensitivity to motion and noise ahfacts. 
Conversely, the main disadvantage is that it must be located at a 
body site where the transducer can look through a web of flesh. Pre- 
vious work at the Mayo Clinic established the ear pina as the most 
promising meamrement site. 
Initial experiments with a non-occlusive opacity transducer indi- 
cated that the pulse wave information obtained was purely qualitative 
and could not be calibrated to measure arterial blood pressure. Subse- 
quent experiments utilized a similar configuration but with the addi- 
tion of the pneumatically operated translucent membrane stretched 
over the light source. This membrane design did not work well for 
diastolic pressure determination, and the annular shaped occluding 
bellows was finally arrived at as the most acceptable design (Figure 4). 
The inlet side of this bellows is connected to a hydraulic system. A 
second bellows at the other end of the hydraulic line is attached to the 
plunger of a solenoid. Pressure at the occluding ear piece is increased 
or decreased by varying the dc current through the solenoid coil. The 
coil its driven by a transistor power amplifier. The frequency response 
of the hydraulic-eleatrical system was from 0 to 10 cps, with some 
response up to 30 cps. 
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FIGURE 4.-Bar Opacity Transducer. 
The light source used in the transducer is a "grain of wheat" lamp 
mounted in the center of the annular occluding bellows. Environ- 
mental light artifacts were succeasfully eliminated by the use of an 
infrared filter and an infrared sensitive phhcell .  
Test Results 
I n  a previous study of 17 subjects E .  H. Wood made simultaneous 
blood pressure determinators using auscultmtion of the brachial ar- 
tery, ear opacity pulse pressure determinations, and a direct indwelling 
catheter in the radial artery. His results showed that pulse pressure 
determinations at the ear were reliable and also more accurate than the 
auscultatory method. American Heart Association Studies have 
shown that determinations by sphygmomanometry typically produce 
systolic pressures that are a minimum of 8 mm Hg  too low and diastolic 
pressures that average 8 mm Hg too high. Test results with the 
Corbin-Parnsworth ear transducers on four subjects produced con- 
sistent results in which systolic pressure was typically 15 mm higher 
and diastolic pressures 5 mm Hg  lower than sphygmomanometry. 
Thus the measurements with the ear transducer should correlate quite 
well with a direct indwelling catheter. 
I n  the above tests little or no discomfort was noted during mlusion 
of the capillaries in the ear pina. In  fact, it was difficult for the sub- 
ject to know when pressure was being applied. One subject wore the 
transducer for more than an hour with partial occlusion and suffered 
no discomfort. Thus the ear transducer appears to be applicable to 
continuous blood pressure monitoring. 
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Further Developmenf 
The development of this transducer appears to be technically com- 
plete. Further experimentation is needed to evaluate the accuracy of 
the ear pulse pressure under various patient conditions and its suscep- 
tibility to artifacts. The hydraulic pressurization system has a fast 
response time and its developers have suggested that a servo system 
might be utilized to make the occlusion pressure follow the waveshape 
of arterial blood pressure. Such a servo system would permit a com- 
plete indication of blood pressure waveshape rather khan simply the 
systolic and diastolic pressure points. 
VIBROCARDIOG'RAPHY 
NASA has supported the development of externally derived cardio- 
vascular diagnostic procedures with grants to  the Institute for Medical 
Research at Cedars of Lebanon Ho~pikal.~ The technique is based upon 
sensing the external manifestation of the forces of cardiovascular dy- 
namics, or more specifically, the local relative motion of the chest wall 
due to movements of the heart itself. The technique is variously 
known as apexcardiography, kinetocardiography, vibrocardiography 
and phonocardiography, depending primarily upon the frequency 
range and choice of motion derivative to be displayed. 
Vibrocardiography, which is the measurement of precordial acceler- 
ations, has been shown to have a high degree of correlation with hemo- 
dynamic events. It has been found that measurement of the phases 
of isometric contraction, ejection, systole and diastole can be obtained 
from the precordial vibration tracing with an accuracy as good as that 
realized with direct cardiac catheterization. Further, comparisons 
of these phase intervals under stress procedures in human and animal 
subjects show significant changes which serve to differentiate the nor- 
mal from the cardiac injured subject,. These changes correlate well 
with other physiological parameters during maximum stress. 
A further means of evaluation is based on the measurement of car- 
diac vibrational energy level during specific phases of the cardiac 
cycle. These measurements have shown consistent changes during 
stress and may well provide a means of determining cardiac mechanical 
force. Recent experimentation has also shown that the vibrocardio- 
gram will provide a method of measuring relative stroke volume, 
thereby yielding s measurement of cardiac output. These findings 
have been compared with known methods of cardiac output and heart 
force determinations and, in preliminary experiments, have shown 
excellent correlation. 
To implement clinical research in vibrocardiography, it has been 
necessary to develop transducers and instrumentation for ?ts measure- 
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ment. In  line with the overall objective of this report, this technical 
review will be limited to a description of the hardware that has been 
currently developed and utilized in NASA supported research work. 
VIBRATION RECORDING TRANSDUCERS 
Extensive study and evaluation of various types of vibration record- 
ing transducers lias resulted in a delineation of the desirable qualities 
of 6hese transducers with respect to the particular application of pre- 
cordial vibration recording. These qualities include (1) a displace- 
ment flat response from at least 2 cps to '2000 cps to permit the record- 
ing of the total energy spectrum of the heart in a form (displacement) 
which has been found to be most valuable; (2) a wide dynamic range 
such that the lower amplitude high frequencies as well as the higher 
energy low frequencies are reproduced ; niid (3)  lightweight and mini- 
mal dimensions to permit usage on human subjects during stress 
procedures. 
Since none of the available transducers fulfilled these needs, further 
tlevelopment of ail "ideal7' transducer was necessitated. To  this end, 
engineers of Ling Temco Vouglit, Inc., working with members of the 
staff of the Institute for Medical Research at Cedars of Lebanon Hos- 
pital have developed a transducer with tlie desired specifications. 
Two models have been used thus far in experiments. These units are 
transistorized for minimal size, have a frequency response of 1.6 to 
3000 cps (+3 db) and a dynamic range of 90 db. Botli of these units 
have been used in experiments witli gratifying results. 
A third model of the LTT transducer was aiinounced during the 
preparation of tlie referenced report. The new unit, designated 
LTV-3, incorporates a number of improvements. Following are sev- 
eral features of the new microphone, which is shown in Figure 5 : 
0 The height has been reduced to %", plus pad. The microphone 
projects %2'' from the base plate and the tentative coupling pad is 
X'' thick silicone rubber. 
0 The case is  made of chrome plated brass with an anodized aluminum 
cover. The microphone diaphragm is now stainless steel and is addi- 
tionally protected with Mylar as before. 
0 To avoid overloading, the sensitivity has been reduced approximately 
15 db. The noise level remains low as  before. 
@ An emitter follower has been incorporated in the unit which provides 
a low impedance, 600 ohm ou,tpuit thus reducing cable noise and hum 
pickup. Tbe output voltage is not affected by this addition. 
0 The low frequency cut-off is adjustaible within limits and can be 
readily modified for acoustic equalization. 
The battery box (shown in the bottom figure) has been enlarged 
for increased battery life (four flashlight cells are used) and a meter 
incoworated which shows the battery condition and indieates when 
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FIGUR~: 6.-Vibr,ocardiographic Transducer. 
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the unit is switched on. A switch, QR, BNC, and phono outputs are 
provided. 
A terminal board is provided in the battery case which can incor- 
porate a preamplifier of greater output voltage if required, or electri- 
cal equalivation if it is desired to reduce the low frequency amplifica- 
tion in order to better fit the dynamic range of typical tape recorders. 
The unit can be completely filled with a silicone potting compound 
to render it impervious to moisture, vibration and similar environ- 
mental influences. Also, the diaphragm spacing in the microphone 
has been doubled to provide greater moisture resistance as well as 
to control the sensitivity. 
INSTRUMENTATION 
Instrumentation for the instantaneous determination of cardiac 
vibrational energy has been completed by modification of a Ballan- 
tine RMS voltmeter. This unit has been adapted to determine 
the energy level of the vibrwardiogram simultaneous with its record- 
ing and will be used in both human and animal experimentation. 
In  addition, circuitry has been developed which will allow the meas- 
urement of vibrational energy during the isometric contraction and 
ejection phase of systole. This equipment provides wave recognition 
circuitry for the location of the significant virbrocardiographic waves 
and gating circuitry which permits measurement and display of both 
energy levels and time between any of these points. 
ELECTRODES 
FLUID ELECTRODE 
Despite half a century of clinical use of the electrocardiogram, a 
great deal of development was necessary to produce an EKG electrode 
acceptable for flight use. Essentially the problem is identical to that 
of recording the EKG during exertion. Many types of electrodes were 
available for use on a working subject, but they were not of sufficiently 
low resistance. I n  addition, most of t.hese systems use standard 
electrode paste or an electrolyte which is hypertonic. After 24 hours 
of contact, the hypertonic nature of the electrode paste causes con- 
siderable irritation to the skin. As the paste dries it loses conduc- 
tivity and effectiveness. 
After a number of trials with various experimental models, a 
"fluid electrode" was finally developed with the desired characteristics. 
The basic principle of this approach is to glue firmly to the skin a non- 
conducting cup containing a non-irritating electrode paste and to use 
this paste as the lead off the skin. The potential is picked up from the 
paste by a shielded wire attached to a metal electrode buried in the 
paste but suspended in the cup so as not to touch the skin. The resist- 
ance of such eleckrodes stays constant if the paste is hygroscopic and 
the cup is well sealed to prevent drying out. 
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PROJECT MERCURY ELECTRODE TECHNIQUES lo 
The first problem mas to find an electrolyte that would remain moist 
and be non-irritating for the duration of a mission. After consider- 
able testing, an electrolyte mas developed for the Mercury Program 
that consisted of 3.0 grams of calcium chloride in 10 cc of water with 
15 grams of bentonite (aluminum silicate powder) to bring it to a 
paste. This electrolyte produced no irritation after 48 hours of use. 
The EKG electrodes consisted of rings composed of silicone rubber, 
constructed to support a disk of 40-mesh stainless steel screen, 30 mm 
in diameter and approximately 2 mm above the skin. The center con- 
ductor of a miniature-type coaxial cable is brought through a strain- 
relieving projection in the rubber ring and soldered to the screen. 
A piece of thermally shrinking plastic tubing seals the cable shield at 
the entrance into the ring to keep out moisture. 
Before the electrode is applied to the washed and shaved skim, a 
coating of elastoplast adhesive is put on the bottom surface of the 
electrode ring and allowed to dry. The ring cavity is then filled with 
electrolyte and applied. After checking the ring cavity and eliminat- 
ing voids, the assembly is sealed with tape and a 4-inch square of mole- 
skin is placed over the entire sensor area. 
This electrode appeared to give less background noise than the 
standard metal plates used in clinical electrocardiography, and also 
less baseline shift when the region to which they were attached was 
actively moved. 
GEMINI ELECTRODE TECHNIQUES "S l3 
Electrodes used on the Gemini flights were modified slightly from 
those developed for Mercury. The more important changes included 
the use of silver-silver chloride electrodes and the preparation of a 
long-term non-irritating electrode paste. 
Electrode Construction 
The stainless steel mesh used initially because of its corrosion resist- 
ance produced considerable motion artifact, probably caused by elec- 
trochemical irreversibility. The unprotected compound metal junc- 
tion of the solder joint mas also a source of spurious potentials. The 
present electrode (Figure 6) is fabricated from a pure silver per- 
forated disk. After applying a coat of epoxy resin to insulate the 
compound metal junction, the disk is anodized in salt solution to pro- 
duce a coating of silver chloride. 
The electrode housing, injection molded from Dow Corning 
S-6015-A silicone rubber, is designed to support the electrode disk 
above the skin in a circular groove. A wide flange facilitates good 
adhesion to the skin. Electrodes fabricated in this manner may be 
used repeatedly. 
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0.030 in. Perforations (No. 53 Dr i l l )  
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FIGURE 6.-Gemini Electrode Construction. 
Electrode Paste 
This electrodes may be used with any electrode paste which contains 
chloride ions. For the repeated long-term applications necessary in 
the space programs, however, a special non-irritating paste was devel- 
oped. Standard EKG pastes are irritating for long periods, especially 
if rubbed in, because the paste contains an abrasive. 
An electrode paste with the same ionic content as ten times that of 
Mammalian Ringer's solution provided a relatively low resistance 
with minimal skin irritation for periods of one week. This paste 
contains no abrasive. Details of the formulation of the present elec- 
trode paste for EKG and impedance pneumography are presented 
in Reference 13. The paste is relatively non-irritating, non-sensitizing, 
and has a long shelf life. This paste must not be used for galvanic skin 
response, skin resistance, or skin potential measurements since it is 
intended to reduce skin resistance. 
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Electrode Application 
This electrode can be applied in less than 3 minutes by an experienced 
technician. A strong non-toxic double-backed tape* is first applied to 
the flange. The flange side of the electrode is then Elled with electrode 
paste. The skin is lightly swabbed with acetone to remove skin oils, 
and the electrode firmly applied. The outer compartment of the 
electrode is then filled to just below the top. A 1-inch square of 
Mystic? tape is applied to close the opening. A 3-inch square of 
Microporel tape is then applied to cover the entire electrode. After 
removing the electrode, the skin is cleansed with Zepharan chloride 
and an antiseptic skin lotion is applied. I n  more than 3 year's experi- 
ence with this procedure, neither irritation nor infection has occurred. 
Long-Term Electrode Tests 
In  addition to numerous short-term tests performed during the 
development of the electrode system, a series of longer duration tests 
was carried out. In  one of these a group of 21 volunteers, in good 
health with no history of dermatitis, wore the electrodes for four days 
(96 hours). The subjects continued their routine jobs, engaged in 
active sports, and took daily showers. The only skin preparation was 
a gentle swabbing with acetone to remove skin oils. 
Except for an initial high resistance that occurs in the first several 
hours while the paste and skin reach equilibrium, the mean skin 
resistance was quite low (less than 25 kilohms) throughout the duration 
of the test. Upon removal of the electrodes, an examination of the 
sites revealed no skin irritation under the electrode paste. Some mild 
irritation was observed under the electrode housing and under the 
Micropore tape; however, this irritation was believed to be largely 
due to mechanical irritation, and uncommon in a relatively inactive 
subject. 
SPRAY-ON ELECTRODE " 
Conventional electrode techniques have disadvantages in many 
situations. They demand special site preparation, relatively large 
electrode areas and considerable time to instslll. To permit routine 
monitoring of test pilots at the NASA Flight Research Center, Ed- 
wards, Calif., a goal of pilot instrumentation and checkout in less than 
three minutes had to be met. One result of the requirement was the 
abnndonment of conventional electrode techniques for the more quickly 
applied conductive paint electrode. This electrode is sprayed on and 
*Scotch No. 1500 Stomaseal (Colostomy) Tape. 
t Mystic Silicone Tape No. 7010. 
8 Scotch Micropore Surgical Tape No. 530. 
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dries almost instantly. A coat of protective spray is applied to the 
finished product. The wires leading to the electrode are Teflon-covered 
copper, approximately the diameter of a hair. An additional advan- 
tage of this electrode technique is that it is much more comfortable 
than conventional electrodes, although of considerably higher 
impedance. 
CHAPTER 4 
The Medical Market 
The prolongation of human lives is the most significant contribution 
that aerospace biomedical technology can make to the national 
economy. 
The full benefits of aerospace medical research and development will 
be realized, however, only if the technology and hardware generated 
are modified and, where necessary, further developed to satisfy the 
specific needs of civilian medicine. In  many cases, a considerable 
investment of money and time may be necessary to implement these 
modifications. To expedite this further development and adaptation 
by private industry it is of utmost importance to demonstrate, where 
possible, that such investments are economically justifiable in terms of 
financial benefits to the potential manufacturer. 
The investment required to adapt or further develop aerospace tech- 
nology and hardware to meet the requirements of civilian medicine is 
difficult, if not impossible, to predict precisely. It will depend upon the 
capabilities, previous experience, and financial structure of the par- 
ticular company involved. I n  some cases, even with unlimited effort, 
development problems will not be amenable to practical solution. No 
attempt is made in this report to quantify or even generalize invest- 
ment costs. Estimates of this type must be made by the prospective 
manufacturer. 
Estimates of the potential market for specific hardware items are, 
however, intrinsic to the functional capabilities of that hardware, and 
not subject to extreme manufacturer-dependent variation. The pur- 
pose of this chapter, therefore, is to explore the nature of the civilian 
medical market, and to develop estimates of the potential dollar volume 
market associated \\-it11 the principal hardware items dwcribed in the 
foregoing sections. 
COURSE OF DEVELOPMENT 
The course of development of medical hardware and its introduction 
tothe market place is considerably different from the normal industrial 
course. I t  is important that firms contemplating entrance to the bio- 
medical field be aware of these differences, and the influence they have 
upon the investment of capital funds in product development. 
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Acceptance of new developments in the medical field generally fol- 
lows a pattern which can be separated into three phases. The first is 
a period of research, development, evaluation on experimental animals, 
and prototype testiilg. The second phase involves limited clinical 
testing and evaluation, usually carried on by only one or two investigat- 
ing groups ; during this period the true clinical value of the technique 
is determined as it is gradually refined and the results are published in 
medical journals. In the third phase the technique is gradually in- 
troduced into the routine of regular medical practice in several loca- 
tions. Only after these rthree phases are successfully completed will 
the new medical product find its way into general use. 
The rate of progression of a medical device through these three 
phases depends upon the fundamental medical technology upon which ' 
the device is based. For rapid progression, the device must be based on 
technology which is widespread and presently understood by a ma- 
jority of practicing medical professionals. If the device involves new 
medical technology, the progression will be slow because of the edu- 
cational time required to incorporate such technology ink0 general 
practice. 
To illustrate this problem, consider the now common technology of 
electrocardiography. The first phase was completed in the 1920's, but 
it was nearly twenty years lsuter that the method found its way into 
general use. I n  fa&, as recently as 1959, more than 10 percent of the 
nation's hospitals still had no ERG equipment. These several decades 
were requir$ to incorporate the basic tecl~nology of EKG into the 
curricula of schools which produced the practitioners versed in the 
art of electrocardiography and created the demand for instrumenta- 
tion of this type. 
At present there is an immediate market for EKG equipment which 
is faster, easier, "better" or cheaper because these adjeoltives have 
readily apparent meaning to practicing cardiologists. Consequently, 
the rate of progression through the three development and acceptance 
phases should be extremely rapid for a clearly superior EKG device. 
The medical profession often has been accused of ultra-conservatism 
in the incorporation of new technology into general practice. The 
problem is deeper, however, than professional conservatism. In fact, 
doctors engaged in research are eager to try new techniques and may 
incorporate new technology very quickly. Unfortunately, the re- 
search device represents only a limited market. A company may fail 
to appreciate the time lag problem if it deals only with groups prac- 
ticing medicine far ahead of thak taught in medical schools. The 
medical product market, then, must have considerations factored into 
it relative to the level of medicine generally practiced. 
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Equipment manufacturers are largely dependent upon the medical 
profession for carrying out the three phases described above. Inde- 
pendent investment to accomplish this work is rarely required because 
of the eagerness of medical research groups to explore new techniques. 
Moreover, the results of clinical work done within the medical profes- 
sion are the only results likely to be accepted promptly by the medical 
community. A cooperative effort by private industry, the medical 
community, and often governmental agencies is frequently a rational 
approach to product development in the biomedical field. 
PATIENT MONITORING MARKET NEEDS 
Technological advances sponsored and funded by NASA in the 
area of physiological measurements reflect the differences between 
aerospace applications and more conventional applications of these 
measurement techniques. The major needs which characterize an 
aerospace application are (1) measurement techniques which are re- 
mote, continuous or semi-continuous, automated, and of relatively long 
duration, and (2) measuring equipment of high reliability, small size, 
weight and power requirements which can operate in an environment 
of high acceleration and vibration without severely restricting or caus- 
ing discomfort to the subject. 
There are a number of medical applications in which these charac- 
teristics offer unique advantages. The most important application ie 
patient monitoring. In  many situations the physician is faced with 
monitoring critically ill persons for protracted periods. For a few 
hours, as in surgical recovery rooms, standard monitoring methods 
such as the blood pressure sphygmomanometer, rectal temperature, and 
observed pulse and respiration rate are perhaps adequate. If the 
pakient requires longer periods of monitoring, however, automated 
remote measurements become a necessity, both in terms of effectiveness 
and economics. 
Although equipment now available is intended to fill this need, a 
number of problems remain. These are related primarily to the trans- 
ducer or sensing system. Present electrode techniques are subject to 
degradation and require periodic repositioning. Monitoring devices 
require frequent calibration and considerably restrict the activity and 
comfort of the subject. Techniques developed for continuous moni- 
toring of subjects during extended space flights are of necessity de- 
signed to minimize such problems. 
INTENSIVE CARE WARDS 
In  the last few years, clinical experience has demonstrated the use- 
fulness of an intensive care ward which is predicated upon close ob- 
servation of the patient and more frequent measurement of vital 
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physiological, electrical, and biochemical variables. The value of 
t,his approach was first proved in surgical recovery rooms, later by 
medical and surgical intensive care wards, and more recently by the 
advent of coronary care wards. 
It has been estimated that properly functioning coronary care wards 
couM save the lives of 100,000 hospital patients each year.14 The 
Committee of Clinical Cardiology of the American Heart Association 
and the Heart Disease Control Program of the U.S. Public Health 
Service have recommended that viotims of acute myocardial infarction 
be cared for in electronically equipped coronary care areas for the 
first few days "since the detection and treatment of potentially lethal 
cardiac arrhythmias require constant observation and prompt action." 
About 85 percent of all deaths from this disease take place in the week 
following the attack. 
According to this report, coronary care units seem desirable and 
practicable in general hospitals, especially those admitting 100 or 
more cases of acute myocardial infarction each year. 
SURGICAL AND POST-OPERATIVE RECOVERY AREAS 
Until a few years ago, continuous monitoring of physiological vari- 
nblm in the operating room was limited to the electroencephalogram 
and the electrocardiogram. At best, these bioelectric potentials reveal 
only gross malfunctions. More recently, methods of obtaining medical 
data from the surgical patient have undergone drastic changes, and 
elecitronic oscillographs and elaborate data acquisition and &display 
systems have become standard aids in several surgical procedures and 
are even found in surgical wards. Blood pressure is a parameter of 
particular importance in surgical procedures and during post-opera- 
tive recovery since it gives an indirect indication of blood volume and 
thus blood loss. 
A simple automated monitor and alarm system designed specifically 
for minor operations could be extremely useful in many situations 
where an anesthesiologist is not needed for other reasons. Such a 
system could allow the physician to concentrate completely upon his 
primary work, yet receive early indication of danger. I n  such appli- 
cations the complexity and convenience of the equipment must be 
weighed carefully against the desired information. True fidelity and 
exaot reproduction of elecitrical waveshapes are not required, which are 
important factors in cost reduction. Continuous information on the 
heart's activity is most desirable. Respiration observations are also 
valuable. Most important, however, would be an automatic alarm 
which would enable the operating physician and other medical per- 
sonnel to concentrate upon their specialized functions. 
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OTHER APPLICATIONS 
Another important area of application is diagnostic monitoring. 
A simple, unencumbering and artifact-free monitoring system would 
be very useful as a diagnostic tool in individual patient examinations. 
Presently, a medical examination is restricted to incomplete informa- 
tion while the patient is at  rest or at  some time after exercise. A 
wireless itransmitter attached to the patient could give a continuous 
picture of the body's changing physiological responses during all 
phases of stress-information which has been thus far unobtainable. 
Still sther important areas of application are medical research and 
public health. Long-term monitoring of normal and abnormal sub- 
jects might result in quantitative descriptions of these abnormalities 
and aid in diagnosis. Rapid techniques Ideveloped for screening astro- 
nauts might also be of use in the mass screening of subjects in public 
health work. 
PATIENT MONITORING MARKET POTENTIAL 
Approximately 5,600 non-Federal short-term general and other spe- 
cial hospitals account for over 90 percent of all hospital admissions 
in this country. Federal, psychiatric, tuberculosis and long-term 
hospikals number about 1,500. Of the short-term hospitals which 
are of principal interest, about 2,100 hospitals have 100 beds or 
more. I n  hospitals of these sizes there are 520,000 beds. 
Applications for patient monitoring within these hospitals exist in 
operating rooms, post operative recovery rooms, intensive care wards 
and coronary care units. 
Almost all intermediate and larger sized hospitals have post-opera- 
tive recovery facilities, either as separate suites adjoining the operat- 
ing rooms, or within the intensive care wards. The average Teugth 
of stay in such facilities is on the order of several hours. The num- 
ber of operating rooms is typically 1.5-3% of the number of hospital 
beds. Assuming an average of one monitoring facility per operating 
room and one for post-operative recovery, one finds a total market 
potential of approximately 15,000 units in surgical and post-operative 
recovery areas. 
The introduction of intensive care wards to meet the needs of criti- 
cally ill patients more effectively has proceeded to the point where 
it is estimated that more than 1,000 hospitals have such units. These 
are usually on a one-per-hospital basis, and of such a size that about 
four intensive care beds are provided for each 100 beds in the hos- 
pital. Coronary care units are just beginning to be introduced into 
hospitals to accommodate victims of myocardial infarctions. About 
30 of these units are now in use. It is desirable to  have them located 
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in proximity to the intensive care wards so that service personnel 
may be shared when emergencies arise. A hospital can expect an 
average of about two coronary cases per year for each regular bed 
in the hospital. The length of patient stay varies between three and 
seven days, depending on the practice in the given hospital. I f  an 
average stay of five days is taken as typical, then 2.5 coronary care 
beds are required for each 100 total beds in the hospital. This figure 
corresponds well with the number found to be adequate in practice. 
Present practice is that a cardiac monitor is provided for each bed 
in the unit. I n  hospitals having 100 beds or more, the saturation po- 
tential would be 13,000 coronary care beds. 
I n  order to estimate the number of early installations, the growth 
history of intensive care units was examined. I n  the case of coronary 
care units, consideration was given to the need that hospitals will 
have for additional space for this new facility adjacent to their in- 
tensive care wards. It is estimated in this manner that during the 
period of most rapid growth, the installation of monitoring units may 
occur at a rate of 2,500 per year. 
I n  discussing the potential market for any device, it is impor- 
tant to recognize that there may be several alternate devices that com- 
pete to satisfy a need. It is necessary to modify overall estimates by 
the expected participation in this market. The most important factor 
in determining the extent of participation are the performance and 
cost of the product. In  the following sections, individual products 
are examined as to their functional performance relative to estab- 
lished needs and their projected selling price to determine annual 
dollar volume of the potential market. 
BLOOD PRESSURE MEASUREMENT 
Direct F O K ~  Blood Pressure Transducer 
The direct force blood pressure measurement system produces a 
continuous external measurement of arterial blood pressure. Its 
principal advantages over comparable automated measurement sys- 
tems are that the full pressure waveform is determined and, since there 
is no occlusion, monitoring is achieved for prolonged periods without 
discomfort. The signal obtained is also suitable for registering the 
pulse rate. The disadvantage is that the initial placement and main- 
tenance of this placement may be a difficult problem that is as yet 
unresolved. 
The needs that such a device can satisfy are in two broad categories : 
those where the complete blood pressure waveform is desired, and 
those where pressure levels only are required on a continuous basis. 
In  the first category, present practice would limit the use to medical 
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research. However, as waveform analysis becomes more thoroughly 
investigated and more persons become experienced in interpreting the 
significance of specific waveforms, a potential exists for use of the 
device as a general diagnostic instrument. The second category, long 
continuous pressure level measurements, satisfies more established 
needs. Expected near term applications are in operating rooms for 
use by anesthesiologists, in post-operative recovery rooms, and in in- 
tensive care wards, particularly coronary care units. 
Neither the manufactured cost nor the required selling price of the 
blood pressure monitoring system can be estimated with any certainty 
now. The manufactured cost depends on the proficiency of the fabri- 
cator and also upon the cost of whatever additional parts may be 
needed to solve the problem of insuring the proper continued posi- 
tioning of the sensor over the artery. Another unknown variable is 
associated with the display unit. Standard oscilloscopes may be used. 
If specially designed, the accuracy and complexity of the display unit 
would have large effects on cost. A rough estimate at this time is that 
the sensor could be built for $100 to $200, and that a satisfactory but 
not elaborate display unit could be made for $200 to $300. Based on 
the customary factor of two between the manufactured cost and selling 
price, the hospital price for a sensor-plus-display package could run 
between $600 and $1,000. These figures are compatible with estimates 
of the required selling price based on corresponding prices of exist- 
ing equipment performing a similar function. The demand might be 
quite elastic above about $1,000, and relatively inelastic at prices much 
below this figure. I n  other words, at  prices much above $1,000 
very few would be sold, and at some price well under $1,000, all who 
could use the product would buy it, so that any further price reduction 
would not significantly increase the number sold. 
As a diagnostic instrument, a further potential exists, deriving its 
value from the possibility of showing the blood pressure waveform. 
I f  and when it is shown that analysis of these waveforms can produce 
useful diagnostic information, doctors having particular interest in 
cardiovascular disease would be expected to acquire the skill necessary 
to interpret these waveforms. The number so interested has been esti- 
mated at 5,000. Selling prices would probably have to be lower than 
khose for the patient monitoring unit since many of the potential cus- 
tomers would be individuals rather than institutions. Required selling 
price is estimated ah $400 to $600 which implies a manufacturing cost 
of $200 to $300. Some decrease in the sensor unit cost may be possible 
as compared to the patient monitoring unit because long term position- 
ing is probably not a problem. The output display which is to show 
waveform probabIy will remain expensive. A simple oscilloscope 
inight be used. A good many cardiac specialists may already have 
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oscilloscopes as part of their EKG equipment. In  this case, the pur- 
chase of an additional display unit would not be required. A manu- 
facturing cost of $100 for the sensor and $100 for the display unit are 
optimistic but not unreasonable. These figures are consistent with a 
$400 selling price. 
Ear Opacity Blood Pressure Transducer 
The ear opacity transducer permits the continuous external measure- 
ment of systolic 'and diastolic pressure. Its outstanding character- 
istics are the ease and uncritical nature of its application to the person, 
and the relative lack of discomfort during occlusion which permits 
semicontinuous, long-term monitoring. Potential disadvantages are 
associated with questionable accuracy which may occur if extraneous 
factors are present (certain anesthetics, drugs, possible sensitivity to 
patient position, etc.) . Additional verification is needed to show that 
peripheral blood pressure measurement is consistently representative 
of the arterial pressure. 
The clearest potential application for this device is a patient moni- 
toring sensor. Measurements could be of the two-point type com- 
monly made (systolic/diastolic), or simply systolic. The extent of 
this applimtion was discussed previously. 
Obtaining pressure waveforms is possible in principle either by using 
a servo to cause the applied pressure to follow the detected pressure 
continuously or by selecting points on the waveform from succwive 
cycles. It might be expected that the higher frequency componenks of 
the waveform would be difficult to detect in the former instance and 
that cycle-to-cycle variations would lead to erroneous readings in the 
lakter. Because these modes of operation have yet to be demonstrated, 
applications for them are not being considered here. 
This transducer requires a source of varying pressure for its opera- 
tion. The transducer output is compared with this source to determine 
the pressure at which occlusion occurs. Therefore, initial sale of the 
transducer will be accompanied by sale of the pressure controller and/ 
or source and an electronic comparison and display unit. 
At an estimated manufactured cost of $15 to $25 for the transducer, 
and $85 to $135 for the source-display unit, the total system cost would 
be $100 to $160. With a factor of two multiplier, the selling price 
would be $200 to $320. Because these figures are considerably lower 
than those for the direct-force system, more units are likely to be sold. 
Subsequent to clinical evaluation, further development work will be 
required on the display unit to evolve a practical unit, and additional 
engineering will be needed to adapt it to production form. 
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Summary of Markets for Blood Pressure Indicators 
The figures developed in the preceding sections are summarized in 
the table below. It is assumed that a display unit would be sold with 
each sensor. The two patient monitoring systems might be in compe- 
tition with each other and with other similar units, so that sales of one 
would subtract from sales of the other. The direct-force blood pressure 
diagnostic instrument involves the display and perhaps analysis of the 
complete pressure waveform. 
Annual Selling Annual 
Quantity Price Market 
Direct-force blood pressure 2,500 $600-$1000 $1.5-2.5 million 
patient monitor. 
Direct-force blood pressure 500 $400-$600 $0.2-0.3 million 
diagnostic instrument. 
Ear occlusion blood pressure 3, 500 $200-$300 $0.7-1.0 million 
patient monitor. 
The sensor which has been under development is an acceleration- 
sensitive transducer which produces an electrical output proportional 
to the mechanical input over a frequency range from a few cycles per 
second to several thousand cycles per second. 
I ts  use as considered in this discussion is in measuring the mechani- 
cal events of the cardiac cycle. It is a natural companion to the electro- 
cardiograph which is responsive to the electrical events of the cardiac 
cycle. The combination would be expected to give valuable informa- 
tion about the functional characteristics of the normal heart, and in 
the future to enable various abnormalities to be identified with a 
superior degree of certainty. Further, the determination would be 
made with little discomfort for the subject. 
Work is currently being done in andyzing and interpreting the 
signals obtained from the VbCG sensor, as discussed previously. The 
results obtained to date show good correlation with measurements 
made in other ways for a number of parameters. Additional work is 
in progress to complete the clinical research necessary for this method 
to become accepted as reliable, informative, and practical. Until this 
work is finished there .\Till be only a research market for equipment in 
this field. 
The cost of the transducer is expected to be comparable to that of 
existing quality microphones. Prices range from a hundred dollars 
upward. Equipment for analyzing the phase, frequency and ampli- 
tude characteristics of the output, signal from the transducer could be 
fairly expensive. This would be particularly true if a large number of 
accurate determinations needed to be made, each involving a different 
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kind of electronic operation. On the other hand, the amount of 
development work required on the analysis equipment will probably 
not be extensive because of the very large variety of electronic ampli- 
fiers, filters, phase detectors, etc., already developed and on the market. 
The application progress in the fielid of vibrocardiography is ex- 
pected to be similar to that of electrocardiography: a period of clin- 
ical research followed by trial use in a limited number of practical 
cases, and then upon demonstration of value in practice, a gradual 
acceptance as a standard technique. Also, as in EKG, the sensor may 
be sold separately from the analysis and display equipment. 
The vibrocardiograph has a very sizable potential market, probably 
comparable to that of the electrocardiograph. However, because the 
vibrocardiogram is presently a research tool, the market for such a 
device in the predictable future is very small, and no attempt to pre- 
dict the dollar volume of this market has been made. 
Biopotential Electrodes 
The functional improvements achieved by NASA developments over 
conventional electrodes are in the increased time period during which 
thwe new electrodes may be used, and the insensitivity to movement 
by the subject. A po~sible~disadvantage is that the procedure of apply- 
ing these electrodes is not as simple ~tnd quick as that for standard 
ones. 
Applications where these improvemente could be of advantage are 
in EKG and respiration monitors where long-term use of the elecrtrode 
is important. These eleotrodes may also be used in diagnostic pro- 
cedures for determining, without motion artifacts, the effects of exer- 
tion upon a subject. 
Thae  electrodes are essentially fully developed and ready for use; 
in fa&, considerable transference of technology already has occurred. 
Several companies are offering for sale a variety of "fluid" electrodes, 
and investigators are using the technology to construct their own elec- 
trodes. For this reason, it was felt that this technology wae not truly 
wikhin the scope and purpose of this report, and it was not given 
further consideration. 
CHAPTER 5 
Summary and Conclusions 
A number of NASA-supported technological advancements have 
been made in aerospace physiological monitoring to meet the par- 
ticular requirements of ;the space program. Several of thew require- 
ments are quite comparable to existing patient monitoring needs in 
civilian medicine. Consequently, many of the improvements and new 
developments generated by the space medical program will also find 
extensive application in civilian medicine. 
Developments which already have prompted considerable transfer of 
technology are exemplified by the auto-sphygmomanometer for remote 
automated blood pressure measurement, and NASA fluid electrode 
techniques for long-term monitoring of biopotentials of active subjects. 
Developments which show potential for transference soon include 
several transducers for the continuous external measurement of blood 
pressure. In  addition, research and development is actively proceed- 
ing on vibrocardiographic evaluation of the activity of the heart and 
there is promise for future transference of this technology. 
Consideration of the developmental status of promising devices for 
indirect blood pressure measurement and a forecast of the potential 
market for these devices has led to the following conclusions: 
Direct Force Blood Pressure Transducer.-The direct force method 
of blood pressure measurement is a new technique for continuous in- 
direct measurement, without occlusion, of the blood pressure waveform 
and ~ 1 1 0 ~ s  great promise for both patient monitoring and diagnosis. 
This device performs a function offered by 110 other device on the 
present market. The remaining development problems, associated 
primarily with positioning, appear formidable though not insurmount- 
able. An annual market potential of 2-3 million dollars exists for such 
a device if it is successfully developed. 
Ear Opacity Blood Pressure Tra.ducer.-The ear opacity trans- 
ducer for blood pressure measurement shows promise as a simple, in- 
expensive monitoring device khak can be easily applied and produces no 
irritation or inconvenience when used continuously. Although fully 
developed, fudher experimental evaluakion and clinical use is neces- 
sary to establish i b  value relative to other similar semi-continuous de- 
vices. The potential market for such a monitor is 0.7-1.0 million 
dollars. 
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